KPIs & Operating Metrics(New)
Biopharma Testing VolumeBreakdown Of AssetsClinical VolumeContractual ObligationsCost Of RevenueCost Of Revenue By SegmentDeferred RevenueEmployee StatisticsGross Margin %Gross Margin By Segment %Gross ProfitGross Profit By SegmentIncome Before Provision For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Revenue (2018 - 2025)

Guardant Health (GH) has disclosed Revenue for 9 consecutive years, with $281.3 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 39.37% to $281.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $982.0 million through Dec 2025, up 32.88% year-over-year, with the annual reading at $982.0 million for FY2025, 32.88% up from the prior year.
  • Revenue hit $281.3 million in Q4 2025 for Guardant Health, up from $265.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $281.3 million in Q4 2025 to a low of $78.7 million in Q1 2021.
  • Historically, Revenue has averaged $155.4 million across 5 years, with a median of $140.1 million in 2023.
  • Biggest five-year swings in Revenue: increased 16.52% in 2021 and later soared 39.37% in 2025.
  • Year by year, Revenue stood at $108.1 million in 2021, then rose by 17.37% to $126.9 million in 2022, then rose by 22.19% to $155.1 million in 2023, then skyrocketed by 30.16% to $201.8 million in 2024, then soared by 39.37% to $281.3 million in 2025.
  • Business Quant data shows Revenue for GH at $281.3 million in Q4 2025, $265.2 million in Q3 2025, and $232.1 million in Q2 2025.